Risk thresholds for alcohol consumption
The Emerging Risk Factors Collaboration. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies.
Lancet. 2018 Apr 14;391(10129):1513-1523. [PubMed]
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve CVD Risk Prediction
The Emerging Risk Factors Collaboration. Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.
Am J Epidemiol. 2017 Oct 15;186(8):899-907. [PubMed]
Cardiometabolic Multimorbidity and Mortality
The Emerging Risk Factors Collaboration. Association of Cardiometabolic Multimorbidity With Mortality.
JAMA. 2015 Jul 7;314(1):52-60. [PubMed]
Covariate-adjusted measures of discrimination
The Emerging Risk Factors Collaboration. Covariate-adjusted measures of discrimination for survival data.
Biom J. 2015 Jul;57(4):592-613. [PubMed]
Metabolic mediators of body-mass index and cardiovascular risk
The Emerging Risk Factors Collaboration. Metabolic mediators of body-mass index and cardiovascular risk.
Lancet. 2014 Jun 14;383(9934):2042-3. [PubMed]
Glycated hemoglobin and cardiovascular risk prediction
The Emerging Risk Factors Collaboration. Glycated hemoglobin measurement and prediction of cardiovascular disease.
JAMA. 2014 Mar 26;311(12):1225-33 [PubMed]
Assessing risk prediction models using multiple studies
The Emerging Risk Factors Collaboration. Assessing risk prediction models using individual participant data from multiple studies.
Am J Epidemiol. 2014 Mar 1;179(5):621-32. [PubMed]
Missing data and IPD meta-analysis
Combining multiple imputation and meta-analysis with individual participant data
Stat Med. 2013 Nov 20;32(26):4499-514. [PubMed]
Correcting for regression dilution bias for calculated risk factors
Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease.
Int J Epidemiol. 2013 Jun;42(3):849-59. [PubMed]
Quantitative effects of metabolic risk factors
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.
PLoS One. 2013;8(7):e65174. [PubMed]
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration. C-reactive protein, fibrinogen, and cardiovascular risk.
N Engl J Med. 2012 Oct 4;367(14):1310-20 [PubMed]
Correspondence: N Engl J Med. 2013 Jan 3;368(1):85-6. [PubMed]
Adult height and cause-specific death
The Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis.
Int J Epidemiol. 2012 Oct;41(5):1419-33. [PubMed]
Lipids and cardiovascular risk prediction
The Emerging Risk Factors Collaboration. Lipid-related markers and cardiovascular disease prediction.
JAMA. 2012;307:2499-2506. [PubMed]
Additional Details: ERFC reply to correspondence, November 21st, 2012, JAMA.
Interleukin-6 receptor pathways and coronary heart disease
IL6R Genetics Consortium and Emerging Risk Factors Collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
Lancet. 2012;379:1205-1213. [PubMed]
Quantifying net benefits of alternative prognostic models
The Emerging Risk Factors Collaboration. A framework for quantifying net benefits of alternative prognostic models.
Stat Med. 2012;31:114-130. [PubMed]
Adiposity measures and vascular risk
The Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
Lancet. 2011;377:1085-95. [PubMed]
Diabetes and cause-specific death
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death.
N Engl J Med. 2011;364:829-841. [PubMed]
Diabetes and vascular risk
The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
Lancet. 2010;375:2215-2222. [PubMed]
Triglyceride-mediated pathways and coronary disease
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
Lancet. 2010;375:1634-1639. [PubMed]
Statistical methods protocol
The Emerging Risk Factors Collaboration. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
Int J Epidemiol. 2010;39:1345-1359. [PubMed]
C-reactive protein concentration and vascular risk
The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Lancet. 2010; 375 (9709):132-40. [PubMed]
Lipids, apolipoproteins and vascular risk
The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease.
JAMA. 2009; 302 (18):1993-2000. [PubMed]
Lipoprotein(a) and vascular risk
The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and non-vascular mortality.
JAMA. 2009; 302 (4):412-23. [PubMed]
ERFC Protocol paper
The Emerging Risk Factors Collaboration. Analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular disease.
Eur J Epidemiol. 2007; 22 (12):839-869. [PubMed]
ERFC protocol update is available here